Olema Oncology to Present at Morgan Stanley 19th Annual Global Healthcare Conference
August 30, 2021 16:05 ET
|
Olema Oncology
SAN FRANCISCO, Aug. 30, 2021 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...
Olema Oncology Reports Second Quarter 2021 Financial Results and Provides Corporate Update
August 10, 2021 16:05 ET
|
Olema Oncology
Presentation of preliminary Phase 1/2 dose-escalation data for OP-1250 in patients with metastatic, ER+ / HER2- breast cancer planned for Q4 2021Strong cash, cash equivalents and marketable securities...
Olema Oncology to Present at Canaccord Genuity 41st Annual Growth Conference
July 28, 2021 16:05 ET
|
Olema Oncology
SAN FRANCISCO, July 28, 2021 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...
Olema Oncology to Participate at the Jefferies 2021 Virtual Healthcare Conference
May 18, 2021 16:05 ET
|
Olema Oncology
SAN FRANCISCO, May 18, 2021 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...
Olema Oncology Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 11, 2021 16:05 ET
|
Olema Oncology
OP-1250 continues to advance in dose-escalation stage of Phase 1/2 clinical trial in patients with metastatic, ER+ / HER2- breast cancer; Initial data anticipated in 2H 2021Cash, cash equivalents, and...
Olema Oncology to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
April 07, 2021 07:30 ET
|
Olema Oncology
SAN FRANCISCO, April 07, 2021 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” NASDAQ: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...
Olema Oncology Appoints Oncology Biotech Executive Yi Larson, MBA, to Board of Directors
April 06, 2021 07:30 ET
|
Olema Oncology
Ms. Larson Brings Significant Biotech Operational Leadership and Global Healthcare Banking Expertise to Olema as the Company Continues to Advance Its PipelineLongstanding Olema Director Dr. Frank...
Olema Oncology Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Updates
March 17, 2021 16:05 ET
|
Olema Oncology
Advancing OP-1250 in metastatic, ER+ / HER2- breast cancer Phase 1/2 clinical trialClinical trial agreements announced with Novartis and Pfizer to explore combination of OP-1250 with CDK4/6 inhibitors...
Olema Oncology Announces Late-Breaking Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2021
March 10, 2021 16:45 ET
|
Olema Oncology
SAN FRANCISCO, March 10, 2021 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”), a clinical-stage biopharmaceutical company focused on the discovery, development and...
Olema Oncology to Participate at Upcoming Virtual Investor Conferences
February 23, 2021 07:00 ET
|
Olema Oncology
SAN FRANCISCO, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” NASDAQ: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...